Loading clinical trials...
Loading clinical trials...
Predictive Value of Nu.Q™ Biomarkers to Help Guiding the Management of Osteoarticular Infections - a Monocentric Prospective Observational Cohort Study
Conditions
Interventions
Histones H3.1 blood levels
Locations
1
Switzerland
University Hospitals Geneva
Geneva, Switzerland
Start Date
October 10, 2022
Primary Completion Date
August 18, 2023
Completion Date
October 31, 2023
Last Updated
May 8, 2024
NCT06383013
NCT07541196
NCT07260656
NCT07039396
NCT06449638
NCT07396376
Lead Sponsor
University Hospital, Geneva
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions